Toolkit/paper-based biosensors
paper-based biosensors
Also known as: paper-based biosensors for point-of-care testing
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Among them, paper-based biosensors have emerged as a promising platform due to their low fabrication cost, simplicity, biodegradability, and compatibility with point-of-care (POC) testing.
Usefulness & Problems
Why this is useful
Paper-based biosensors are presented as a platform for rapid, cost-effective, portable, and quantitative detection in prostate cancer diagnostics. The review frames them as promising point-of-care tools.; point-of-care testing; prostate cancer detection; rapid and portable diagnostics
Source:
Paper-based biosensors are presented as a platform for rapid, cost-effective, portable, and quantitative detection in prostate cancer diagnostics. The review frames them as promising point-of-care tools.
Source:
point-of-care testing
Source:
prostate cancer detection
Source:
rapid and portable diagnostics
Problem solved
They address the need for low-cost, simple, and field-deployable diagnostic tools for early prostate cancer detection and monitoring.; providing low-cost and portable diagnostic platforms; supporting sensitive and quantitative detection in point-of-care settings
Source:
They address the need for low-cost, simple, and field-deployable diagnostic tools for early prostate cancer detection and monitoring.
Source:
providing low-cost and portable diagnostic platforms
Source:
supporting sensitive and quantitative detection in point-of-care settings
Problem links
providing low-cost and portable diagnostic platforms
LiteratureThey address the need for low-cost, simple, and field-deployable diagnostic tools for early prostate cancer detection and monitoring.
Source:
They address the need for low-cost, simple, and field-deployable diagnostic tools for early prostate cancer detection and monitoring.
supporting sensitive and quantitative detection in point-of-care settings
LiteratureThey address the need for low-cost, simple, and field-deployable diagnostic tools for early prostate cancer detection and monitoring.
Source:
They address the need for low-cost, simple, and field-deployable diagnostic tools for early prostate cancer detection and monitoring.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Mechanisms
Translation ControlTechniques
Selection / EnrichmentTarget processes
selectiontranslationImplementation Constraints
Their performance depends on the selection and engineering of sensing materials, and the abstract notes added value from nanomaterials and surface modification strategies.; requires appropriate sensing material selection and engineering; benefits from nanomaterial integration and surface modification strategies
The abstract states that major challenges still impede clinical translation, so the platform is not yet established as a fully reliable field-ready clinical solution.; clinical translation barriers remain; performance depends on selection and engineering of sensing materials
Validation
Supporting Sources
Ranked Claims
Paper-based biosensors can enable highly sensitive and quantitative detection, with performance depending strongly on the selection and engineering of sensing materials.
Paper-based biosensors are a promising platform for point-of-care prostate cancer testing because they offer low fabrication cost, simplicity, biodegradability, and portability-compatible use.
Major challenges still impede the clinical translation of paper-based biosensors from research prototypes to reliable field-ready tools for early prostate cancer diagnosis and monitoring.
Approval Evidence
Among them, paper-based biosensors have emerged as a promising platform due to their low fabrication cost, simplicity, biodegradability, and compatibility with point-of-care (POC) testing.
Source:
Paper-based biosensors can enable highly sensitive and quantitative detection, with performance depending strongly on the selection and engineering of sensing materials.
Source:
Paper-based biosensors are a promising platform for point-of-care prostate cancer testing because they offer low fabrication cost, simplicity, biodegradability, and portability-compatible use.
Source:
Major challenges still impede the clinical translation of paper-based biosensors from research prototypes to reliable field-ready tools for early prostate cancer diagnosis and monitoring.
Source:
Comparisons
Source-stated alternatives
The abstract contrasts paper-based biosensors with the widely used PSA test and more broadly references other biosensor platforms for prostate cancer detection.
Source:
The abstract contrasts paper-based biosensors with the widely used PSA test and more broadly references other biosensor platforms for prostate cancer detection.
Source-backed strengths
low fabrication cost; simplicity; biodegradability; compatibility with point-of-care testing
Source:
low fabrication cost
Source:
simplicity
Source:
biodegradability
Source:
compatibility with point-of-care testing
Compared with biosensors
The abstract contrasts paper-based biosensors with the widely used PSA test and more broadly references other biosensor platforms for prostate cancer detection.
Shared frame: source-stated alternative in extracted literature
Strengths here: low fabrication cost; simplicity; biodegradability.
Relative tradeoffs: clinical translation barriers remain; performance depends on selection and engineering of sensing materials.
Source:
The abstract contrasts paper-based biosensors with the widely used PSA test and more broadly references other biosensor platforms for prostate cancer detection.
Compared with biosensors for active Rho detection
The abstract contrasts paper-based biosensors with the widely used PSA test and more broadly references other biosensor platforms for prostate cancer detection.
Shared frame: source-stated alternative in extracted literature
Strengths here: low fabrication cost; simplicity; biodegradability.
Relative tradeoffs: clinical translation barriers remain; performance depends on selection and engineering of sensing materials.
Source:
The abstract contrasts paper-based biosensors with the widely used PSA test and more broadly references other biosensor platforms for prostate cancer detection.
Compared with fluorescent protein based reporters and biosensors
The abstract contrasts paper-based biosensors with the widely used PSA test and more broadly references other biosensor platforms for prostate cancer detection.
Shared frame: source-stated alternative in extracted literature
Strengths here: low fabrication cost; simplicity; biodegradability.
Relative tradeoffs: clinical translation barriers remain; performance depends on selection and engineering of sensing materials.
Source:
The abstract contrasts paper-based biosensors with the widely used PSA test and more broadly references other biosensor platforms for prostate cancer detection.
Compared with genetically engineered biosensors
The abstract contrasts paper-based biosensors with the widely used PSA test and more broadly references other biosensor platforms for prostate cancer detection.
Shared frame: source-stated alternative in extracted literature
Strengths here: low fabrication cost; simplicity; biodegradability.
Relative tradeoffs: clinical translation barriers remain; performance depends on selection and engineering of sensing materials.
Source:
The abstract contrasts paper-based biosensors with the widely used PSA test and more broadly references other biosensor platforms for prostate cancer detection.
Ranked Citations
- 1.